Financials

News Discussions Technicals Seasonals

688202 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Shanghai Medicilon, Inc. engages in the preclinical comprehensive research and development services of biomedicine. It provides drug discovery, pharmaceutical research, and preclinical research services. It offers AIDS drugs, anti-cancer drug sensitizers, genetically engineered vaccines and biomedical intermediates. The company was founded by Jin Zhang Chen and Chun Lin Chen on February 2, 2004 and is headquartered in Shanghai, China.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

688202 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company